🇮🇳 Zydus Lifesciences Ltd
Get Zydus Lifesciences Ltd filings on Telegram the moment they are published.
Follow Zydus Lifesciences Ltd on TelegramOne tap starts your 30-day free trial. No card needed.
Overview: Zydus Therapeutics reported Phase 2b trial results for saroglitazar magnesium, showing 39.1% and 32.4% resolution of steatohepatitis in MASH patients versus 13.7% for placebo.
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest